Intranasal oxytocin for autism spectrum disorders (ASD)

  • Protocol
  • Intervention

Authors

  • Lei Feng,

    1. Yong Loo Lin School of Medicine, National University of Singapore, Department of Psychological Medicine, Singapore, Singapore
    Search for more papers by this author
  • John CM Wong,

    Corresponding author
    1. Yong Loo Lin School of Medicine, National University of Singapore, Department of Psychological Medicine, Singapore, Singapore
    • John CM Wong, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kend Ridge Road, Singapore, 119228, Singapore. pcmwcmj@nus.edu.sg.

    Search for more papers by this author
  • Rathi Mahendran,

    1. Yong Loo Lin School of Medicine, National University of Singapore, Department of Psychological Medicine, Singapore, Singapore
    Search for more papers by this author
  • Edwin SY Chan,

    1. Office of Clinical Sciences, Duke-NUS Graduate Medical School, Centre for Quantitative Medicine, Singapore, Singapore
    Search for more papers by this author
  • Michael D Spencer

    1. University of Cambridge, Autism Research Centre, Department of Psychiatry, Cambridge, England, UK
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy of intranasal oxytocin in improving social interaction and communication deficit, and other clinical outcomes in autism spectrum disorders (ASD), and to examine its safety.